Maarouf A. Hoteit, MD
Professor of Clinical Medicine (Gastroenterology)
Director of Multidisciplinary Liver Tumor Clinic, Hospital of the University of Pennsylvania
Medical Director of Liver Transplantation, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Liver Transplant Program
3400 Spruce Street
2 Dulles
Philadelphia, PA 19104
Liver Transplant Program
3400 Spruce Street
2 Dulles
Philadelphia, PA 19104
Office: (215) 349-5581
Fax: 215-615-1601
Fax: 215-615-1601
Education:
BS (Biology)
American University of Beirut, 1996.
MD
American University of Beirut, 2000.
Permanent linkBS (Biology)
American University of Beirut, 1996.
MD
American University of Beirut, 2000.
Description of Clinical Expertise
Liver CancerLiver Transplantation
Description of Research Expertise
Liver CancerLiver Transplantation
Selected Publications
Ferrante ND, Hubbard RA, Weinfurtner K, Mezina AI, Newcomb CW, Furth EE, Bhattacharya D, Njei B, Taddei TH, Singal A, Hoteit MA, Park LS, Kaplan D, Lo Re V 3rd.: Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes. Pharmacoepidemiol Drug Saf May 2025.Kappus MR, Hughes D, Ganger D, Kim Y, Bashir M, Bonn J, Borhani A, Fetzer D, Fischer R, Gabriel H, Guindi M, Hecht E, Hoteit M, Khanna G, Krasuski R, Lewis S, Mavis A, Miller F, Morin C, Schiano T, Schooler G, Shingina A, Sirlin C, Singal A, Taouli B, Tompkins R, Zaidi A, VanWagner L, Yokoo T.: A survey of national practice patterns of hepatocellular carcinoma surveillance for patients with fontan-associated liver disease: A call to action. Liver Transpl Apr 2025.
Singal AG, Yang JD, Jalal PK, Salgia R, Mehta N, Hoteit MA, Kao K, Daher D, El Dahan KS, Hernandez P, Nayak A, Kim N, Pham S, Gamez J, Troost JP, Parikh ND.: Patient-perceived risk of HCC and net benefit of surveillance: A multi-center survey study. Am J Gastroenterol Apr 2025.
Hoteit MA, Weinfurtner K.: Recurrent HCC after liver transplantation: Small steps, while awaiting a breakthrough. Liver Transpl 31: 421-422, Apr 2025.
Kim YY, Nyman A, Huang YS, Tomlinson AZ, McRae MP, Everson GT, Vaikunth S, Rosenthal B, Rychik J, Hoteit MA.: Alterations in Liver Perfusion in Adults With Fontan Circulation as Assessed by Dual Cholate Clearance. J Am Heart Assoc Mar 2025.
Rosenthal BE, Hoteit MA, Lluri G, Haeffele C, Daugherty T, Krasuski RA, Serfas JD, de Freitas RA, Porlier A, Lubert AM, Wu FM, Valente AM, Krieger EV, Buber Y, Rodriguez FH 3rd, Gaignard S, Saraf A, Hindes M, Earing MG, Lewis MJ, Rosenbaum MS, Zaidi AN, Hopkins K, Bradley EA, Cedars AM, Ko JL, Franklin WJ, Frederickson A, Ginde S, Grewal J, Nyman A, Min J, Schluger C, Rand E, Hilscher M, Rychik J, Kim YY.: Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation. JACC Adv 4: 101646, Mar 2025.
Xu E, Tabrizian P, Gutierrez J, Hoteit M, Ghaziani T, Zhou K, Parikh N, Ajmera V, Aby E, Shui A, Marino R, Martin A, Wong C, Kao K, Dave S, Florman S, Yao F, Mehta N.: Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study. Hepatology Jan 2025.
Taj R, Ng K, Cuddapah SR, Rand EB, Bleicher M, Amaral S, Hoteit MA, Reddy RK, Feyssa E, Furth EE, Olthoff KM, Abu-Gazala S, Levine MH, Vyas F, Abt PL.: Liver Transplant From a Deceased Donor With Cystinosis: A Case Report. JIMD Rep 66: e12467, Jan 2025.
Parra NS, Hoteit MA, Rattan P, Abt P, Mahmud N.: Trends in candidate HCV NAT+ listing and associated impacts on liver transplantation waitlist outcomes. Am J Transplant Oct 2024.
Tabrizian P, Holzner M, Ajmera V, Kim AK, Zhou K, Schnickel GT, Torosian K, Hoteit M, Marino R, Li M, Yao F, Florman SS, Schwartz ME, Mehta N: Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: the multicenter VITALITY study. J Hepatol Sep 2024 Notes: 2024 Sep 8:S0168-8278(24)02541-8. doi: 10.1016/j.jhep.2024.09.003. Online ahead of print.